Brimonidine + Brinzolamide is a prescription eye drop that combines two pressure-lowering medicines in one bottle: brimonidine tartrate 0.2% and brinzolamide 1%. It is used to reduce raised pressure inside the eye (intraocular pressure) in adults who have open-angle glaucoma or ocular hypertension, two conditions in which high eye pressure can damage the optic nerve over time. Brinzolamide belongs to the carbonic anhydrase inhibitor group, while brimonidine belongs to the alpha-2 adrenergic agonist group. Because the two ingredients lower eye pressure in different ways, the fixed combination is used when one medicine alone is not enough. It is a sterile suspension that has to be shaken before each use.
Glaucoma is a group of eye conditions in which the optic nerve, the bundle of nerve fibres that carries what you see to the brain, becomes damaged. Raised pressure inside the eye is the main risk factor for that damage, and it happens quietly: glaucoma does not usually cause symptoms, and most people do not realise they have it until it is picked up during a routine eye test. Worldwide, glaucoma is one of the leading causes of vision impairment and blindness, and the sight it takes away cannot be brought back.
Brimonidine + Brinzolamide is prescribed for adults with open-angle glaucoma, the commonest form, or with ocular hypertension, which means eye pressure that is higher than normal before any nerve damage has appeared. It is a fixed-dose combination, so both active ingredients come in one bottle: brinzolamide 1%, a carbonic anhydrase inhibitor, and brimonidine tartrate 0.2%, an alpha-2 adrenergic agonist. Carbonic anhydrase inhibitors and alpha-2 agonists are two well-established families of eye pressure medicine, and pairing them means pressure is lowered in two different ways at once.
The bottle holds a sterile suspension, not a clear solution, so it has to be shaken before each use to mix the medicine evenly. The usual schedule is one drop in each affected eye three times a day. In two three-month studies, using the two ingredients together lowered pressure by about 1 to 3 mmHg (millimetres of mercury, the units used to measure eye pressure) more than using either brinzolamide 1% or brimonidine 0.2% on its own.
Because this is a prescription medicine, it needs medical supervision, and your eye doctor will check your eye pressure and look at the optic nerve regularly. The drops are not suitable for everyone: they must not be used by babies and children under two years, they are not recommended if your kidneys are severely impaired, and they need caution in severe heart or liver disease. Brimonidine + Brinzolamide lowers eye pressure but does not repair vision that has already been lost, which is why keeping to the schedule and keeping every follow-up appointment matters.
Common Side Effects (Usually Mild and may lessen with continued use)
In the label's two three-month studies, 435 people received this combination. The most frequent reactions, seen in about 3% to 5% of them, were blurred vision, eye irritation, a bitter taste, dry mouth and eye allergy, and 11% of people stopped treatment, mostly because of side effects. Used on its own, brimonidine 0.2% caused dry mouth, eye redness, burning and stinging, headache and drowsiness in roughly 10% to 30% of people, while brinzolamide 1% caused blurred vision and a bitter or sour taste in roughly 5% to 10%.
Serious Side Effects (Seek Urgent Medical Attention)
These drops go into the eye only. Nothing is swallowed, crushed or chewed, so the usual tablet rules do not apply.
The label asks for this routine three times a day, at about the same times each day, roughly eight hours apart. Keep to those times rather than fitting doses around how your eyes feel. If you need more than one drop in the same eye, wait at least five minutes before the next drop. If you also use any other eye medicine, leave at least 10 minutes between it and these drops. Keep using Brimonidine + Brinzolamide even when your eyes feel completely normal, and do not change the number of doses on your own.
Inside the front part of the eye there is a clear fluid called aqueous humour, which is not the same as tears. It keeps the eye firm and nourished. It is made by a ring of tissue called the ciliary body and drains away through channels at the edge of the iris. If the eye makes too much of this fluid, or if the drainage is poor, the pressure inside the eye rises, and over years that pressure damages the optic nerve.
Both ingredients in Brimonidine + Brinzolamide lower that pressure, but they act on different targets.
Brinzolamide is a carbonic anhydrase inhibitor. Carbonic anhydrase is an enzyme, a protein that speeds up a chemical reaction in the body. It sits in the ciliary processes, the fluid-making part of the eye. Brinzolamide blocks this enzyme, which slows the formation of bicarbonate ions and in turn reduces the movement of sodium and water. The result is that the eye makes less aqueous humour. Its peak effect on pressure is two to three hours after a dose.
Brimonidine tartrate is an alpha-2 adrenergic receptor agonist. It attaches to alpha-2 receptors in the eye and has two effects at once: it reduces how much aqueous humour is produced, and it increases uveoscleral outflow, which means fluid leaves through the tissues at the base of the eye rather than only through the main drainage channel. Its peak effect is about two hours after a dose.
Because one ingredient blocks an enzyme and the other switches on a receptor, the two work on separate pathways. That is why the combination lowers pressure further than either ingredient alone, and why it is used when a single medicine has not been enough.
The label states that there are no adequate, well-controlled studies of Brimonidine + Brinzolamide in pregnant women, so it is used only if the possible benefit justifies the possible risk to the baby. In animal studies, brinzolamide given by mouth to rabbits and rats at many times the human eye dose caused reduced fetal body weight and minor fetal variations but no malformations linked to the treatment, and brimonidine tested in rats did not harm the fetus. Tell your eye doctor if you are pregnant, think you may be pregnant or are planning a pregnancy.
After eye drops it is not known whether brinzolamide or brimonidine passes into human milk. In animals, brinzolamide appeared in milk at levels below those in blood, and brimonidine was found in breast milk. The label advises weighing the benefit of the treatment against the risk to the baby, which may include stopping nursing, while the brimonidine patient leaflet advises not to breast-feed while using brimonidine eye drops. Talk to your doctor before using Brimonidine + Brinzolamide if you are breast-feeding.
Alcohol can add to the drowsiness and light-headedness that brimonidine may cause. The label lists alcohol among the central nervous system depressants that can have an additive effect with this medicine. Ask your doctor whether drinking alcohol is safe for you while you use these drops.
Your vision may be blurred for a short time after each dose, and brimonidine can make some people sleepy or dizzy. Do not drive, cycle or use machines until you know how Brimonidine + Brinzolamide affects you.
The combination has not been studied in people with severe kidney impairment, described in the label as a creatinine clearance below 30 mL/min, a measure of how well the kidneys filter. Because brinzolamide and its breakdown products leave the body mainly through the kidneys, the label does not recommend Brimonidine + Brinzolamide in this group. Tell your doctor if you have kidney disease so your treatment can be reviewed.
Brimonidine has not been studied in people with liver impairment, and the label advises caution in severe liver disease. Tell your eye doctor about any liver condition before you start these drops.
Brimonidine + Brinzolamide is not for children. It must not be used in newborns and infants under two years of age, because brimonidine has caused serious effects in that age group, including extreme sleepiness, slow heartbeat, low blood pressure and breathing difficulty. In studies of related eye drops, 50% to 83% of children aged two to six years became very sleepy. The combination has not been shown to be safe and effective in children.
The label reports no overall difference in safety or effectiveness between older adults and younger adults, so age alone does not call for a change in dose. Older adults are more likely to have other health conditions and to take other medicines, so their doctor may review everything together.
Therapeutic Class
Antiglaucoma medicine (eye pressure lowering agent)
Action Class
Alpha-2 adrenergic receptor agonist plus carbonic anhydrase inhibitor
Chemical Class
Brimonidine tartrate is a quinoxaline derivative; brinzolamide is a thienothiazine sulfonamide
Habit Forming
No
Checkout Editorial Policy
Top Selling Medicines
Top Health Products
Top Selling Devices
Brimonidine 0.2% w/v + Brinzolamide 1% w/v

₹280.3

₹307.2
MRP ₹480
Brimonidine 0.2% w/v + Brinzolamide 1% w/v

₹525.5

₹307.2
MRP ₹480
Brimonidine 0.2% w/v + Brinzolamide 1% w/v

₹499.1

₹307.2
MRP ₹480
Brimonidine 0.2% w/v + Brinzolamide 1% w/v

₹543.7

₹307.2
MRP ₹480
Brimonidine 0.2% w/v + Brinzolamide 1% w/v

₹393.8

₹307.2
MRP ₹480
Brimonidine 0.2% w/v + Brinzolamide 1% w/v

₹403.1

₹307.2
MRP ₹480
Brimonidine 0.2% w/v + Brinzolamide 1% w/v

₹497.6

₹307.2
MRP ₹480
Brimonidine 0.2% w/v + Brinzolamide 1% w/v

₹731.9

₹307.2
MRP ₹480
Brimonidine 0.2% w/v + Brinzolamide 1% w/v

₹585.9

₹307.2
MRP ₹480
Brimonidine 0.2% w/v + Brinzolamide 1% w/v

₹365.6

₹307.2
MRP ₹480
Brimonidine 0.2% w/v + Brinzolamide 1% w/v

₹470

₹307.2
MRP ₹480
Brimonidine 0.1% w/v + Brinzolamide 1% w/v

₹382.8
MRP ₹466.9
Brimonidine 0.2% w/v + Brinzolamide 1% w/v

₹306.6

₹307.2
MRP ₹480
Brimonidine 0.2% w/v + Brinzolamide 1% w/v

₹750

₹307.2
MRP ₹480
Brimonidine 2mg + Brinzolamide 10mg + Timolol 5mg

₹441.2
MRP ₹538
Brimonidine 0.2% w/v + Brinzolamide 1% w/v

₹618.8

₹307.2
MRP ₹480
Brimonidine 0.1% w/v + Brinzolamide 1% w/v

₹459.3

₹382.8
MRP ₹466.9
Brimonidine 0.2% w/v + Brinzolamide 1% w/v

₹459

₹307.2
MRP ₹480
Brimonidine 2mg + Brinzolamide 10mg + Timolol 5mg

₹609.4

₹441.2
MRP ₹538
Brimonidine 0.2% w/v + Brinzolamide 1% w/v

₹307.2
MRP ₹480
Brimonidine 0.2% w/v + Brinzolamide 1% w/v

₹635

₹307.2
MRP ₹480
Brimonidine 0.2% w/v + Brinzolamide 1% w/v

₹515.6

₹307.2
MRP ₹480
Brimonidine 0.2% w/v + Brinzolamide 1% w/v

₹384.4

₹307.2
MRP ₹480
Brimonidine 0.2% w/v + Brinzolamide 1% w/v

₹374.1

₹307.2
MRP ₹480
Brimonidine 0.2% w/v + Brinzolamide 1% w/v

₹370.3

₹307.2
MRP ₹480